1. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.
- Author
-
Brydges, Susannah D, Broderick, Lori, McGeough, Matthew D, Pena, Carla A, Mueller, James L, and Hoffman, Hal M
- Subjects
- *
ANIMAL experimentation , *BIOLOGICAL models , *BONE marrow , *CARRIER proteins , *CELL death , *CELL receptors , *INTERLEUKIN-1 , *INTERLEUKINS , *LIVER , *MICE , *GENETIC mutation , *PROTEINS , *PROTEOLYTIC enzymes , *RESEARCH funding , *SKIN , *CRYOPYRIN-associated periodic syndromes - Abstract
The inflammasome is a cytoplasmic multiprotein complex that promotes proinflammatory cytokine maturation in response to host- and pathogen-derived signals. Missense mutations in cryopyrin (NLRP3) result in a hyperactive inflammasome that drives overproduction of the proinflammatory cytokines IL-1β and IL-18, leading to the cryopyrin-associated periodic syndromes (CAPS) disease spectrum. Mouse lines harboring CAPS-associated mutations in Nlrp3 have elevated levels of IL-1β and IL-18 and closely mimic human disease. To examine the role of inflammasome-driven IL-18 in murine CAPS, we bred Nlrp3 mutations onto an Il18r-null background. Deletion of Il18r resulted in partial phenotypic rescue that abolished skin and visceral disease in young mice and normalized serum cytokines to a greater extent than breeding to Il1r-null mice. Significant systemic inflammation developed in aging Nlrp3 mutant Il18r-null mice, indicating that IL-1 and IL-18 drive pathology at different stages of the disease process. Ongoing inflammation in double-cytokine knockout CAPS mice implicated a role for caspase-1-mediated pyroptosis and confirmed that CAPS is inflammasome dependent. Our results have important implications for patients with CAPS and residual disease, emphasizing the need to explore other NLRP3-mediated pathways and the potential for inflammasome-targeted therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013